Acyclovir NDC 70700-107

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-107Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0107Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-107-15	70700010715	1 TUBE in 1 CARTON (70700-107-15) / 15 g in 1 TUBEMarketed from Jan 30, 2020
70700-107-16	70700010716	1 TUBE in 1 CARTON (70700-107-16) / 30 g in 1 TUBEMarketed from Jan 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acyclovir
Generic name (nonproprietary): acyclovir
Active ingredients: Acyclovir — 50 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Xiromed, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201501
Marketing start: Jan 30, 2020
Listing expires: Dec 31, 2026
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 70700-107_9ef6e425-efa1-aec8-223d-fc9a670767b3SPL ID 9ef6e425-efa1-aec8-223d-fc9a670767b3SPL set ID 3e222423-3bf2-6584-6d54-447b1b26dc42RxCUI 197312UNII X4HES1O11FUPC 0370700107164
Pharmacologic class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470700010715 followed by a unit qualifier and the quantity

Package 70700-0107-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acyclovir Ointment USP, 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous HSV infections in immunocompromised patients.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201501

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201501
Product	Strength	Form · route	Labeler	Product NDC
Acyclovir	Acyclovir 50 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-2328
Acyclovir	Acyclovir 50 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-2327
Acyclovir	Acyclovir 50 mg/g	OintmentTopical	Bryant Ranch Prepack	72162-1960